This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Stocks in play: Medicenna Therapeutics Corp.
Announced today that it has finalized the terms of its previously-announced marketed underwritten public offering of securities of the Company, being an offering of units of the Company at a price to the public of $0.50 per Unit. Each Unit will be comprised of one common share of the Company and one half of one warrant of the Company. Medicenna Therapeutics Corp. shares T.MDNA are trading down $0.04 at $0.50.
